SA
DXCM icon

Seneschal Advisors’s DexCom DXCM Stock Holding History

Seneschal Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203 Sell
3
-2
-40% -$133 ﹤0.01% 539
2026
Q1 		$314 Buy
5
+3
+150% +$209 ﹤0.01% 468
2025
Q4 		$133 Sell
2
-1
-33% -$65 ﹤0.01% 560
2025
Q3 		$202 Buy
+3
New +$237 ﹤0.01% 533

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Seneschal Advisors's DXCM Position: Q2 2026 in Review

Seneschal Advisors reduced its DexCom (DXCM) stake by 40% in Q2 2026, selling an estimated $133 and leaving 3 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Seneschal Advisors first reported a position in DXCM in Q3 2025 and has held it in 4 quarters since. The position peaked at $314 in Q1 2026. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Seneschal Advisors held 3 shares of DexCom worth $203 as of Q2 2026.
  • Seneschal Advisors sold 2 DexCom shares in Q2 2026, an estimated $133.
  • DexCom made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #539 holding.
  • Seneschal Advisors first reported a position in DexCom in Q3 2025 and has held it in 4 quarters since.
  • Seneschal Advisors's DexCom position peaked at $314 in Q1 2026.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.